Cui, Pingping <br/><br/>
Zoledronate promotes bone formation by blocking osteocyte-osteoblast communication during bone defect healing.  [electronic resource] 

 -  Histology and histopathology  Jan 2018 
 - 89-99 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1699-5848 
<br/><br/><label>Standard No.: </label>10.14670/HH-11-893  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adaptor Proteins, Signal Transducing<br/>Alkaline Phosphatase--metabolism<br/>Animals<br/>Bone Density Conservation Agents--pharmacology<br/>Cell Communication--drug effects<br/>Connexin 43--metabolism<br/>Diphosphonates--pharmacology<br/>Disease Models, Animal<br/>Extracellular Matrix Proteins--metabolism<br/>Femoral Fractures--drug therapy<br/>Fracture Healing--drug effects<br/>Glycoproteins--metabolism<br/>Imidazoles--pharmacology<br/>Intercellular Signaling Peptides and Proteins<br/>Male<br/>Mice<br/>Osteoblasts--drug effects<br/>Osteoclasts--drug effects<br/>Osteocytes--drug effects<br/>Osteogenesis--drug effects<br/>Signal Transduction--drug effects<br/>Tartrate-Resistant Acid Phosphatase--metabolism<br/>Time Factors<br/>Zoledronic Acid